PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 59 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

29 November 2024

  1. (diff | hist) m b 09:16 Oral semaglutide 3,213 +676 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  2. (diff | hist) 08:27 Bacteriostatic water 3,438 +607 TitrationTheo (talk | contribs) move a stray full stop inside the reference [rollback]
  3. (diff | hist) 08:19 Amino acid analysis 2,367 +324 TirzTaxonomist (talk | contribs) split §Principle from §Practical limitations [rollback]
  4. (diff | hist) 07:08 Tianjin Finder Chemical 3,772 +696 TallySheetTad (talk | contribs) add category for suppliers in China [rollback]
  5. (diff | hist) N 05:50 Peptide stability table 1,273 +1,273 BalanceBirdie (talk | contribs) new article: reference tool, expansion welcome
  6. (diff | hist) 02:17 Active pharmaceutical ingredient 1,752 +609 LabelLibby (talk | contribs) add the customs-detention point with its source [rollback]

28 November 2024

  1. (diff | hist) m 23:39 Contract development and manufacturing organisation 2,252 ±0 CouplingCillian (talk | contribs) expand §Consequences for reading documentation [rollback]
  2. (diff | hist) m 21:23 Number needed to treat 2,730 +450 TelehealthTruus (talk | contribs) expand §Calculation [rollback]
  3. (diff | hist) 18:40 Amylin 3,238 ±0 DiffWatchDov (talk | contribs) close an unbalanced quotation mark [rollback]
  4. (diff | hist) 14:58 Reconstitution of lyophilised peptides 3,676 +558 LeanMassLars (talk | contribs) sentence case in headings per PP:MOS [rollback]
  5. (diff | hist) 13:38 Prescribing information 2,473 ±0 GlossaryGleb (talk | contribs) alphabetise the see-also list [rollback]
  6. (diff | hist) 09:25 Purity claim inflation 2,887 +217 BlindSampleBrid (talk | contribs) correct the description of the sampling procedure [rollback]
  7. (diff | hist) m 07:34 Chain of custody 2,966 ±0 GHK_Gwendolen (talk | contribs) convert the service comparison to a table [rollback]
  8. (diff | hist) m 07:33 Hypoglycaemia 3,334 +844 ChainCustodyChad (talk | contribs) add the contraindication with its rationale [rollback]
  9. (diff | hist) 06:16 Custom peptide synthesis 2,690 ±0 ResinRhoswen (talk | contribs) expand §Documentation for custom work [rollback]
  10. (diff | hist) m 05:08 High-performance liquid chromatography 4,315 +112 KarlFischerKit (talk | contribs) convert a hard-coded date to the house format [rollback]
  11. (diff | hist) 03:15 Janoshik Analytical 3,638 ±0 RedirectRini (talk | contribs) British spelling per PP:MOS [rollback]

27 November 2024

  1. (diff | hist) 21:24 Batch number 3,013 +31 COA_Colwyn (talk | contribs) state the date range the submitted set covers [rollback]
  2. (diff | hist) 18:31 Hunan Aslsen Technology 5,413 +501 FootnoteFyfe (talk | contribs) expand §Ordering and availability [rollback]
  3. (diff | hist) N 09:00 Personal importation policy 1,572 +1,572 StabilityStig (talk | contribs) create article — regulatory stub
  4. (diff | hist) 08:35 Lyophilisation 10,767 +508 CrossRefCleve (talk | contribs) state that overlay gas is used and name it [rollback]
  5. (diff | hist) m 08:07 Peptide aggregation 3,081 +38 LOD_Lorcan (talk | contribs) fix a broken wikilink [rollback]
  6. (diff | hist) m b 06:09 Solid-phase peptide synthesis 3,963 +102 ArchiveBot (talk | contribs) bot: normalise temperature formatting [rollback]
  7. (diff | hist) 03:38 Semaglutide 6,658 ±0 Chromatokid (talk | contribs) add a hatnote pointing at the analogue with the similar name [rollback]
  8. (diff | hist) m 03:31 VendorInvestigate 2,881 +31 PurityClaimPia (talk | contribs) alphabetise the see-also list [rollback]
  9. (diff | hist) 03:23 Dose escalation schedule 2,748 +29 SyringeSybille (talk | contribs) add the disclaimer that this is not administration guidance [rollback]
  10. (diff | hist) m b 01:02 Adverse effects of GLP-1 receptor agonists 4,129 +958 CategoryBot (talk | contribs) bot: normalise citation format [rollback]
  11. (diff | hist) 00:38 USP General Chapter 71 1,714 ±0 GlossaryGaspar (talk | contribs) state the titration endpoint and the reagent factor [rollback]

26 November 2024

  1. (diff | hist) 21:17 Sarcopenia 1,173 ±0 Peptide_Pete (talk | contribs) add the body-composition measurement method to the comparison [rollback]
  2. (diff | hist) 18:06 SURMOUNT trial programme 2,702 +34 PatientPanelPru (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  3. (diff | hist) 14:22 Shanghai Sigma-Audley New Material Technology 2,709 ±0 SurrogateSunday (talk | contribs) space between number and unit per PP:MOS [rollback]
  4. (diff | hist) m 10:47 Bachem Holding (Suzhou) 4,859 +222 DiagramDelphine (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  5. (diff | hist) 03:39 Reconstitution calculator 3,369 ±0 SourceHunterSile (talk | contribs) copyedit [rollback]
  6. (diff | hist) 00:17 SURPASS trial programme 3,661 +34 GastroparesisGwen (talk | contribs) cite the trial publication rather than the sponsor press release [rollback]

25 November 2024

  1. (diff | hist) m 20:54 Gastric emptying 3,836 +44 Ref_Desk_Ron (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 18:37 Sterile water for injection 3,062 +643 OralSemaOswin (talk | contribs) add the diluent volume the example assumes [rollback]
  3. (diff | hist) 14:12 Contraindications of incretin therapy 2,065 ±0 SiteReactionSuz (talk | contribs) rm a duplicated category [rollback]
  4. (diff | hist) 13:35 Body composition assessment 1,910 ±0 BlankVialBo (talk | contribs) expand §Methods and their precision [rollback]
  5. (diff | hist) 10:53 Fasting insulin 2,254 ±0 ApoB_Aurelio (talk | contribs) expand §Why it needs glucose alongside it [rollback]
  6. (diff | hist) 09:03 Beyond-use date 6,130 +1,252 EndotoxinEd (talk | contribs) consistent en dashes in ranges [rollback]
  7. (diff | hist) N 09:00 Active pharmaceutical ingredient 1,143 +1,143 SyringeSybille (talk | contribs) start article on the regulatory position
  8. (diff | hist) m 04:18 CagriSema 2,861 +600 LabRangeLindy (talk | contribs) add the structural figure and caption it properly [rollback]
  9. (diff | hist) m b 04:02 PeptideMeter 2,876 ±0 CiteBot (talk | contribs) bot: flag bare reference [rollback]
  10. (diff | hist) m 03:34 Amino acid analysis 2,043 ±0 COA_Colwyn (talk | contribs) correct the integration description — valley-to-valley, not drop-line [rollback]

24 November 2024

  1. (diff | hist) 16:52 Growth hormone secretagogue 2,667 +825 MOTSc_Mira (talk | contribs) the solubility figure needs its solvent stated [rollback]
  2. (diff | hist) m b 15:26 Satiety signalling 3,938 +704 CiteBot (talk | contribs) bot: sort category members [rollback]
  3. (diff | hist) 15:02 Research use only 4,722 +996 SelectTrialSam (talk | contribs) add the jurisdiction to the legal statement [rollback]
  4. (diff | hist) m 14:43 Glucagon 4,787 +590 DulaglutideDug (talk | contribs) space between number and unit per PP:MOS [rollback]
  5. (diff | hist) m b 14:37 Exenatide 2,935 ±0 ArchiveBot (talk | contribs) bot: add drug-class category [rollback]
  6. (diff | hist) 14:11 SELECT trial 3,502 ±0 BlindSampleBrid (talk | contribs) attribute the subgroup finding as exploratory [rollback]
  7. (diff | hist) 09:23 Chinese Peptide Company 6,679 +782 PeakShapePol (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  8. (diff | hist) 08:37 Talk:Shanghai Sigma-Audley New Material Technology 1,033 +60 NotabilityNoa (talk | contribs) /* Notability and the registered business scope */ reply
  9. (diff | hist) m b 06:45 Arcuate nucleus 3,033 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) 05:51 Repackaging 2,904 ±0 ResinRhoswen (talk | contribs) expand §Why the record is the whole thing [rollback]
  11. (diff | hist) m b 04:35 Preparative HPLC purification 3,390 +29 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) m 03:32 Lixisenatide 2,302 +255 LotTraceLuka (talk | contribs) state which salt form the mass in the infobox refers to [rollback]

23 November 2024

  1. (diff | hist) 21:10 Cold-chain freight 2,385 +271 MelanocortinMil (talk | contribs) add the customs-detention point as a logistics fact, sourced [rollback]
  2. (diff | hist) m 19:34 GL Biochem (Shanghai) 8,549 +883 FiveOhThreeA (talk | contribs) expand §Operations and documentation practice [rollback]
  3. (diff | hist) m 13:14 Mass spectrometry 4,018 +137 ColumnOvenCoy (talk | contribs) ce, tighten prose [rollback]
  4. (diff | hist) 10:41 Weight regain after discontinuation 2,939 +117 ITT_Imelda (talk | contribs) add the rebound point with the follow-up study it comes from [rollback]
  5. (diff | hist) m 09:54 Albumin binding half-life extension 3,310 +153 NavboxNiko (talk | contribs) add the counter-regulatory glucagon point, sourced [rollback]
  6. (diff | hist) 05:44 TRIUMPH trial programme 2,837 ±0 ForestPlotFinn (talk | contribs) split overlong sentence [rollback]
  7. (diff | hist) m 05:02 Drug master file 2,196 +407 HarmReductionHen (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]

22 November 2024

  1. (diff | hist) 23:49 Loss on drying 2,569 ±0 LeanMassLars (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  2. (diff | hist) m b 15:20 Subcutaneous injection 3,690 +704 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 13:09 Melanotan II 1,177 ±0 Hedgerow_Hal (talk | contribs) split overlong sentence [rollback]
  4. (diff | hist) m 10:24 Orforglipron 1,574 ±0 SemaglutideSasha (talk | contribs) British spelling per PP:MOS [rollback]
  5. (diff | hist) 10:07 Talk:Beyond-use date 1,170 +181 FiveOhThreeA (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  6. (diff | hist) 10:03 Talk:Shanghai Sigma-Audley New Material Technology 822 +211 Hedgerow_Hal (talk | contribs) /* Notability and the registered business scope */ reply
  7. (diff | hist) N 09:00 Sarcopenia 1,173 +1,173 ApoB_Aurelio (talk | contribs) new article: laboratory medicine, expansion welcome
  8. (diff | hist) 06:02 STEP trial programme 4,022 +113 DrTitration (talk | contribs) space between number and unit per PP:MOS [rollback]
  9. (diff | hist) m b 03:59 Cagrilintide 2,938 +532 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  10. (diff | hist) 01:33 ChinaPeptides 3,956 +1,017 COA_Colwyn (talk | contribs) expand §Distribution and dispatch [rollback]

21 November 2024

  1. (diff | hist) 22:43 GLP-1 receptor 5,187 +119 SatietySunniva (talk | contribs) convert the receptor-distribution list to a table [rollback]
  2. (diff | hist) 20:40 Sterility testing 2,614 ±0 NewLabNell (talk | contribs) convert the method-comparison paragraph to a table [rollback]
  3. (diff | hist) m b 18:14 Customs seizure 1,799 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 12:15 Talk:Shanghai Sigma-Audley New Material Technology 611 +269 ScopeSeverin (talk | contribs) /* Notability and the registered business scope */ reply
  5. (diff | hist) 11:04 Talk:Tianjin Finder Chemical 1,033 +129 CDMO_Caradoc (talk | contribs) /* Manufacturer or distributor? */ reply
  6. (diff | hist) 10:34 ISO 9001 2,449 ±0 AnalyticalAnnie (talk | contribs) fix the anchor on an internal link [rollback]
  7. (diff | hist) m 10:14 C-peptide 2,537 ±0 LabRangeLindy (talk | contribs) fix indentation in the source [rollback]
  8. (diff | hist) 09:48 Talk:Shanghai Sigma-Audley New Material Technology 400 +409 NotabilityNoa (talk | contribs) /* Notability and the registered business scope */ new section
  9. (diff | hist) 09:35 Regulatory status by jurisdiction 2,139 ±0 GreyMarketGreer (talk | contribs) clarify that a business licence is not a manufacturing authorisation [rollback]
  10. (diff | hist) m 06:59 Trifluoroacetate counterion 2,739 ±0 LOD_Lorcan (talk | contribs) clarify the difference between related substances and total impurities [rollback]
  11. (diff | hist) 04:10 Liraglutide 3,273 ±0 CuriousCallum (talk | contribs) the half-life in the lead was the terminal figure; label it as such [rollback]
  12. (diff | hist) 01:47 Retatrutide 4,481 +404 AppendixAlva (talk | contribs) rm the equipotency claim — the cited paper does not make it [rollback]
  13. (diff | hist) m 01:03 Deamidation 2,307 +287 Retention_Time_Rae (talk | contribs) correct the water-content figure — the source reports it on a dry basis [rollback]

20 November 2024

  1. (diff | hist) 21:18 Enteroendocrine L cell 3,351 ±0 GlossaryGleb (talk | contribs) the article treated a rodent finding as human physiology; corrected [rollback]
  2. (diff | hist) 20:43 Vial filling and stoppering 2,480 +465 FmocFrancis (talk | contribs) add the figure for the lyophilisation cycle and caption it [rollback]
  3. (diff | hist) 20:24 Underfilling 1,727 +619 Ref_Desk_Ron (talk | contribs) clarify that a QR code on a certificate proves issuance, not content [rollback]
  4. (diff | hist) 16:16 Peptide content 3,952 +429 NauseaNoor (talk | contribs) add category for method validation [rollback]
  5. (diff | hist) 15:31 Cold chain 15,523 +1,581 eGFR_Esme (talk | contribs) add the crimp-seal step to the fill-and-finish description [rollback]
  6. (diff | hist) m b 15:07 Purity claim inflation 2,670 +432 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 13:37 Bacterial endotoxin test 2,929 ±0 KarlFischerKit (talk | contribs) add the forced-degradation conditions the claim rests on [rollback]
  8. (diff | hist) 11:56 Survodutide 2,514 +1,058 IcodecIndra (talk | contribs) state the substitution in one-letter code as well, per PP:MOS [rollback]
  9. (diff | hist) N 09:00 Orforglipron 1,574 +1,574 SemaglutideSasha (talk | contribs) new article: compound, expansion welcome
  10. (diff | hist) 08:52 Talk:Beyond-use date 959 +161 CitationChaser (talk | contribs) /* The 25% rule keeps being reinstated */ reply
  11. (diff | hist) 08:12 Insulin syringe unit conversion 1,989 +494 OpenLabelOtto (talk | contribs) add the caveat that concentration and dose are not the same quantity [rollback]
  12. (diff | hist) 05:30 Customs seizure 1,799 +747 Compounding_Cate (talk | contribs) correct the description of the shortage-list mechanism [rollback]
  13. (diff | hist) 04:40 WuXi TIDES 7,117 +1,195 SecondarySrc_Seb (talk | contribs) add the incorporation year, attributed to the registry record [rollback]
  14. (diff | hist) m b 03:14 GLP-1 receptor agonist 8,122 +1,583 CiteBot (talk | contribs) bot: expand DOI to full citation [rollback]